A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened
- PMID: 24018987
- DOI: 10.1002/cncr.28199
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened
Abstract
Background: Mortality reduction from mammographic screening is controversial. Individual randomized trials and meta-analyses demonstrate statistically significant mortality reductions in all age groups invited to screening. In women actually screened, mortality reductions are greater. Individual trials and meta-analyses show varying rates of mortality reduction, leading to questions about screening's value and whether treatment advances have diminished the importance of early detection. This study hypothesized that breast cancer deaths predominantly occurred in unscreened women.
Methods: Invasive breast cancers diagnosed between 1990 and 1999 were followed through 2007. Data included demographics, mammography use, surgical and pathology reports, and recurrence and death dates. Mammograms were categorized as screening or diagnostic based on absence or presence of breast signs or symptoms, and were substantiated by medical records. Breast cancer deaths were defined after documentation of prior distant metastases. Absence of recurrent cancer and lethal other diseases defined death from other causes.
Results: Invasive breast cancer failure analysis defined 7301 patients between 1990 and 1999, with 1705 documented deaths from breast cancer (n = 609) or other causes (n = 905). Among 609 confirmed breast cancer deaths, 29% were among women who had been screened (19% screen-detected and 10% interval cancers), whereas 71% were among unscreened women, including > 2 years since last mammogram (6%), or never screened (65%). Overall, 29% of cancer deaths were screened, whereas 71% were unscreened. Median age at diagnosis of fatal cancers was 49 years; in deaths not from breast cancer, median age at diagnosis was 72 years.
Conclusions: Most deaths from breast cancer occur in unscreened women. To maximize mortality reduction and life-years gained, initiation of regular screening before age 50 years should be encouraged.
Keywords: breast cancer; cancer; mammography; mortality; screening.
Copyright © 2013 American Cancer Society.
Comment in
-
Reply to A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.Cancer. 2014 Sep 15;120(18):2937-8. doi: 10.1002/cncr.28525. Epub 2013 Dec 18. Cancer. 2014. PMID: 24353038 No abstract available.
-
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.Cancer. 2014 Sep 15;120(18):2936-7. doi: 10.1002/cncr.28528. Epub 2013 Dec 18. Cancer. 2014. PMID: 24353077 No abstract available.
-
Breast cancer screening: time for rational discourse.Cancer. 2014 Sep 15;120(18):2800-2. doi: 10.1002/cncr.28788. Epub 2014 Jun 12. Cancer. 2014. PMID: 24925095 No abstract available.
-
The 20-year effort to reduce access to mammography screening: historical facts dispute a commentary in Cancer.Cancer. 2014 Sep 15;120(18):2792-9. doi: 10.1002/cncr.28791. Epub 2014 Jun 12. Cancer. 2014. PMID: 24925233
-
Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: application to an article in Cancer.Cancer. 2014 Sep 15;120(18):2784-91. doi: 10.1002/cncr.28795. Epub 2014 Jun 12. Cancer. 2014. PMID: 24925345
Similar articles
-
Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9. Br J Cancer. 2017. PMID: 28183141 Free PMC article.
-
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.Health Technol Assess. 2020 Oct;24(55):1-24. doi: 10.3310/hta24550. Health Technol Assess. 2020. PMID: 33141657 Free PMC article. Clinical Trial.
-
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.Lancet. 2003 Apr 26;361(9367):1405-10. doi: 10.1016/S0140-6736(03)13143-1. Lancet. 2003. PMID: 12727392
-
Mammography in symptomatic and asymptomatic patients.Hematol Oncol Clin North Am. 1989 Dec;3(4):611-40. Hematol Oncol Clin North Am. 1989. PMID: 2691492 Review.
-
A systematic assessment of benefits and risks to guide breast cancer screening decisions.JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398. JAMA. 2014. PMID: 24691608 Review.
Cited by
-
Breast cancer outcomes based on method of detection in community-based breast cancer registry.Breast Cancer Res Treat. 2024 Jan;203(2):215-224. doi: 10.1007/s10549-023-07092-x. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878149
-
Misinformation and Facts about Breast Cancer Screening.Curr Oncol. 2022 Aug 9;29(8):5644-5654. doi: 10.3390/curroncol29080445. Curr Oncol. 2022. PMID: 36005183 Free PMC article.
-
Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.BMC Med. 2022 Aug 4;20(1):239. doi: 10.1186/s12916-022-02440-y. BMC Med. 2022. PMID: 35922814 Free PMC article.
-
Marrying Story with Science: The Impact of Outdated and Inconsistent Breast Cancer Screening Practices in Canada.Curr Oncol. 2022 May 13;29(5):3540-3551. doi: 10.3390/curroncol29050286. Curr Oncol. 2022. PMID: 35621676 Free PMC article.
-
Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment.Am Surg. 2022 Jun;88(6):1051-1053. doi: 10.1177/00031348221087920. Epub 2022 Apr 13. Am Surg. 2022. PMID: 35417262 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
